Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InflaRx (IFRX) Other Operating Expenses (2022 - 2025)

Historic Other Operating Expenses for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to -$1.4 million.

  • InflaRx's Other Operating Expenses rose 2709.91% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.0 billion, marking a year-over-year increase of 1982.68%. This contributed to the annual value of -$55222.7 billion for FY2022, which is N/A changed from last year.
  • Per InflaRx's latest filing, its Other Operating Expenses stood at -$1.4 million for Q3 2025, which was up 2709.91% from -$13.0 billion recorded in Q2 2025.
  • In the past 5 years, InflaRx's Other Operating Expenses ranged from a high of $19685.6 billion in Q1 2023 and a low of -$53456.5 billion during Q4 2022
  • Its 4-year average for Other Operating Expenses is -$5370.6 billion, with a median of -$1.7 million in 2023.
  • Examining YoY changes over the last 5 years, InflaRx's Other Operating Expenses showed a top increase of 1.0568607536306386e26% in 2023 and a maximum decrease of 15094734069.13% in 2023.
  • Quarter analysis of 4 years shows InflaRx's Other Operating Expenses stood at -$53456.5 billion in 2022, then skyrocketed by 100.0% to -$1.7 million in 2023, then dropped by 10.26% to -$1.9 million in 2024, then rose by 27.1% to -$1.4 million in 2025.
  • Its last three reported values are -$1.4 million in Q3 2025, -$13.0 billion for Q2 2025, and -$1.5 million during Q1 2025.